Sean Maduck
2020
In 2020, Sean Maduck earned a total compensation of $3.2M as Chief Commercial Officer at Corcept Therapeutics, a 43% increase compared to previous year.
Compensation breakdown
| Bonus | $214,157 |
|---|---|
| Option Awards | $2,508,404 |
| Salary | $474,380 |
| Total | $3,196,941 |
Maduck received $2.5M in option awards, accounting for 78% of the total pay in 2020.
Maduck also received $214.2K in bonus and $474.4K in salary.
Rankings
In 2020, Sean Maduck's compensation ranked 3,640th out of 13,090 executives tracked by ExecPay. In other words, Maduck earned more than 72.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,640 out of 13,090 | 72nd |
Division Manufacturing | 1,426 out of 5,621 | 75th |
Major group Chemicals And Allied Products | 538 out of 2,254 | 76th |
Industry group Drugs | 467 out of 1,954 | 76th |
Industry Pharmaceutical Preparations | 353 out of 1,459 | 76th |
Source: SEC filing on April 22, 2021.
Maduck's colleagues
We found four more compensation records of executives who worked with Sean Maduck at Corcept Therapeutics in 2020.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019